Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 241 - 260 of 481 trials
Title Investigatorsort icon Disease(s)
A Phase II Study of Paclitaxel/Carboplatin versus Bleomycin/Etoposide/Cisplatin for Patients with Advanced Ovarian Stromal Tumors Who Have Not Received Chemotherapy
Relapsed/Refractory
[Protocol 13-177]
Leitao, Mario
  • Ovarian Cancer
A Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy with or without Adjuvant Chemotherapy in High-Risk Patients with Early-Stage Cervical Cancer Following Radical Hysterectomy
[Protocol 10-173]
Leitao, Mario
  • Cervical Cancer
A Phase I/II Study of Paclitaxel, Cisplatin, and ABT-888 (Velaparib) to Treat Advanced, Persistent, or Recurrent Cervical Cancer
[Protocol 11-131]
Leitao, Mario
  • Cervical Cancer
Evaluation of Physical Function and Quality of Life Before and After Non-Radical Surgery for Stage I Cervical Cancer
Newly Diagnosed
[Protocol 13-210]
Leitao, Mario
  • Cervical Cancer
  • Quality of Life
A Phase IB Study of SAR650984 with Lenalidomide and Dexamethasone to Treat Recurrent or Persistent Multiple Myeloma
[Protocol 13-006]
Lendvai, Nikoletta
  • Hematology
    • Multiple Myeloma
A Phase II Study of Carfilzomib with or without ARRY-520 in Patients with Advanced Multiple Myeloma
[Protocol 13-241]
Lendvai, Nikoletta
  • Hematology
    • Multiple Myeloma
Adaptation of Meaning-Centered Psychotherapy for Chinese Immigrant Cancer Patients
[Protocol 14-076]
Leng, Jennifer
  • Psychiatry & Behavioral Sciences
A Phase II Study of Siltuximab in Patients with High-Risk Smoldering Multiple Myeloma
Newly Diagnosed
[Protocol 12-068]
Lesokhin, Alexander
  • Hematology
    • Multiple Myeloma
A Phase I Study of BMS-936558 in Patients with Relapsed or Refractory Hematologic Cancers
Relapsed/Refractory
[Protocol 12-142]
Lesokhin, Alexander
  • Hematology
    • Multiple Myeloma
  • Leukemia
    • Chronic Myelocytic Leukemia
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
Assessment of a Customized Computer Program for Reducing Fears of Breast Cancer Recurrence
[Protocol 11-204]
Lichtenthal, Wendy
  • Breast Cancer
  • Psychiatry & Behavioral Sciences
  • Survivorship
Development of Group Interventions for Breast Cancer Survivors
[Protocol 12-291]
Lichtenthal, Wendy
  • Breast Cancer
  • Survivorship
A Phase I/II Study of Gemcitabine, Cisplatin, and MEK162 as Initial Treatment for Advanced Bile Duct or Gallbladder Cancer
[Protocol 13-004]
Lowery, Maeve
  • Hepatobiliary
  • Upper Gastrointestinal
A Pilot Trial of Irinotecan, Temozolomide, and Bevacizumab plus High-Dose Chemotherapy for Newly Diagnosed Patients with Desmoplastic Small Round Cell Tumor
[Protocol 10-091]
Magnan, Heather
A Phase I/II Study of Sunitinib in Young Patients with Advanced Gastrointestinal Stromal Tumors
Newly Diagnosed & Relapsed/Refractory
[Protocol 12-226]
Magnan, Heather
  • Sarcomas
    • Soft Tissue Sarcoma
  • Upper Gastrointestinal
A Phase II Study of Irinotecan and Temozolomide in Combination with Existing High-Dose Chemotherapy for Patients Newly Diagnosed with Ewing Sarcoma
[Protocol 13-068]
Magnan, Heather
  • Sarcomas
    • Ewing's Sarcoma
    • Soft Tissue Sarcoma
A Phase II Study of Dalantercept for Treating Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 13-109]
Makker, Vicky
  • Ovarian Cancer
A Phase II Study of Cabozantinib versus Paclitaxel to Treat Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 13-048]
Makker, Vicky
  • Ovarian Cancer
A Phase II Trial of a WT-1 Vaccine in Patients with Acute Myeloid Leukemia
[Protocol 10-143]
Maslak, Peter
A Phase III Study of Ofatumumab versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Relapsed/Refractory
[Protocol 11-079]
Matasar, Matthew
  • Lymphoma
    • Non-Hodgkin's Lymphoma
Assessment of Heart Tissue in Survivors of Hodgkin Lymphoma
[Protocol 14-017]
Matasar, Matthew
  • Lymphoma
    • Hodgkin's Disease
  • Survivorship